CURASIGHT A/S
CVR 35249389 · Public limited company (A/S) · Active · Medium risk
CURASIGHT A/S is a Public limited company (A/S), founded on , based in København N. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 2.6% over the next 12 months, which is 1.9 times the average for Danish companies. 13 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 17.9m and a net result of DKK -53.2m.
Bankruptcy risk for CURASIGHT A/S
1.9 × the average (1.41%) · higher risk than 86% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 35249389
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (13 years)
- Address
- Ole Maaløes Vej 3
2200 København N - Municipality
- København
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 2.5m
- Employees
- 2 (2018)
- Auditor
- PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 13 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 35.8% |
| Current ratio | 137% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 167 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK -49.7m | DKK -32.7m | DKK -25.7m |
| Net profit | DKK -53.2m | DKK -36.8m | DKK -26.2m |
| Equity | DKK 17.9m | DKK 7.7m | DKK 31.4m |
| Total assets | DKK 50.1m | DKK 23.7m | DKK 38.7m |
| Cash | DKK 35.9m | DKK 10.0m | – |
| Short-term debt | DKK 32.1m | DKK 16.0m | – |
| Avg. employees | 4 | 4 | – |
Latest annual report: Reporting class B · auditor's statement: Auditor's report on audited financial statements · PricewaterhouseCoopersStatsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 131 | ||
| 1 Jan 2024 – 31 Dec 2024 | 163 | ||
| 1 Jan 2023 – 31 Dec 2023 | 103 | ||
| 1 Jan 2022 – 31 Dec 2022 | 92 | ||
| 1 Jan 2021 – 31 Dec 2021 | 131 | ||
| 1 Jan 2020 – 31 Dec 2020 | 110 | ||
| 1 Jan 2019 – 31 Dec 2019 | 167 | ||
| 1 Jan 2018 – 31 Dec 2018 | 176 | ||
| 1 Jan 2017 – 31 Dec 2017 | 151 | ||
| 1 Jan 2016 – 31 Dec 2016 | 152 | ||
| 1 Jan 2015 – 31 Dec 2015 | 152 | ||
| 1 Jan 2014 – 31 Dec 2014 | 149 | ||
| 22 May 2013 – 31 Dec 2013 | 147 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| Board | Ulrich Alexander Krasilnikoff | Current | |
| Board | Kirsten Aarup Drejer | Current | |
| Board | Andreas Kjær | Current | |
| Board | Colin Richard William Hayward | Current | |
| Board | Marcel Reichen | Current | |
| Board | Carsten Haagen Nielsen | ||
| Board | Morten Persson | ||
| Board | Jacob Madsen | ||
| Board | Andreas Kjær | ||
| Board | Frank Knudsen | ||
| Board | Lars Trolle | ||
| Board | Line Holten Reimer | ||
| Board | Jon Ingi Benediktsson | ||
| Board | Morten Persson | ||
| Board | Nicolas Némery | ||
| Board | André Klaus Hess | ||
| Board | Ulf Lennart Rosén | ||
| Board | Lutz Helmke | ||
| Board | Per Falholt | ||
| Board | Lars Trolle | ||
| Board | Charlotte Vedel | ||
| Board | Kirsten Aarup Drejer | ||
| Owner (15%) | AK 2014 HOLDING ApS | Current | |
| Owner (5%) | CHN 2014 HOLDING ApS | Current | |
| Owner (10%) | UK Curacap ApS | Current | |
| Owner (15%) | Curium Netherlands B.V | Current | |
| Owner (5%) | UBS AG LONDON BR A/C EQUITIES | Current | |
| Owner (15%) | PreSeed Ventures A/S | ||
| Owner (20%) | AK 2014 HOLDING ApS | ||
| Owner (20%) | CHN 2014 HOLDING ApS | ||
| Owner (20%) | NOE SF HOLDING ApS | ||
| Owner (20%) | MADSEN HOLDING 2013 ApS | ||
| Owner (25%) | PreSeed Ventures A/S | ||
| Owner (10%) | AK 2014 HOLDING ApS | ||
| Owner (10%) | CHN 2014 HOLDING ApS | ||
| Owner (10%) | NOE SF HOLDING ApS | ||
| Owner (10%) | MADSEN HOLDING 2013 ApS | ||
| Owner (10%) | UK Curacap ApS | ||
| Owner (10%) | Eckert & Ziegler Radiopharma GmbH | ||
| Owner (15%) | Uddannelses- og Forskningsstyrelsen | ||
| Owner (15%) | PreSeed Ventures A/S | ||
| Owner (5%) | AK 2014 HOLDING ApS | ||
| Owner (5%) | CHN 2014 HOLDING ApS | ||
| Owner (5%) | NOE SF HOLDING ApS | ||
| Owner (5%) | MADSEN HOLDING 2013 ApS | ||
| Owner (15%) | SEED Capital Denmark III K/S | ||
| Owner (5%) | UK Curacap ApS | ||
| Owner (25%) | Eckert & Ziegler Radiopharma GmbH | ||
| Owner (25%) | AK 2014 HOLDING ApS | ||
| Owner (15%) | CHN 2014 HOLDING ApS | ||
| Owner (5%) | MADSEN HOLDING 2013 ApS | ||
| Owner (20%) | CURASIGHT A/S | ||
| Owner (25%) | UK Curacap ApS | ||
| Owner (10%) | CHN 2014 HOLDING ApS | ||
| Owner (20%) | UK Curacap ApS | ||
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | Current | |
| Auditor | ERNST & YOUNG DENMARK P/S | ||
| Auditor | EY Godkendt Revisionspartnerselskab | ||
| Auditor | Grant Thornton, Godkendt Revisionspartnerselskab | ||
| Founder | AK 2014 HOLDING ApS | Current | |
| Founder | CHN 2014 HOLDING ApS | Current | |
| Founder | NOE SF HOLDING ApS | Current | |
| Founder | MADSEN HOLDING 2013 ApS | Current |
Address history (1 moves)
| Ole Maaløes Vej 3, 2200 København N | |
| Marielystvej 11, 2000 Frederiksberg |
Former names
| CURASIGHT A/S | – now |
| CURASIGHT ApS | – |
Employees per year
Other companies at the same address
- 25-06-2019 ApS Bankrupt
- Ankrin Therapeutics ApS Bankrupt
- Avineuro ApS Bankrupt
- BIOREPELLER IVS Bankrupt
- Bainan Biotech ApS Bankrupt
- Broselid Holding IVS Bankrupt
- ChildTreat ApS Bankrupt
- Dencomm ApS Bankrupt
- IO BIOTECH ApS Bankrupt
- Invitreo Biosciences ApS Bankrupt
- Lab Hos Development ApS Bankrupt
- MGM BIO IVS Bankrupt
- Mind the Byte ApS Bankrupt
- PanCryos ApS Bankrupt
- Ressaissi Holding IVS Bankrupt
- SSIP 2023 ApS Bankrupt
- Spit Test Company ApS Bankrupt
- Sterisafe Holding A/S Bankrupt
- Sumondo ApS Bankrupt
- TychoBio IVS Bankrupt
- aiwell Nordic ApS Bankrupt
- 1stBiome ApS Active
- 3Sonic ApS Active
- 55 North General Partner I ApS Active
- 55 North Management ApS Active
Similar companies in København
- CARLSBERG A/S København V
- CuraVision ApS København V
- Launch Bioindustries ApS København Ø
- RheumaLogics ApS København Ø
- Vitibiotech ApS København N
- Pyovita ApS Hellerup
- ArcanaBio ApS København N
- OvartiX ApS København N
- Keystone Consulting ApS København SV
- KPL ApS København N
- Alveus Therapeutics ApS København K
- Cambiotics ApS København N
Questions and answers about CURASIGHT A/S
Has CURASIGHT A/S gone bankrupt?
No, CURASIGHT A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of CURASIGHT A/S?
Our model estimates a bankruptcy risk of 2.6% over the next 12 months (medium risk), which is 1.9 times the average for Danish companies.
Who is the auditor of CURASIGHT A/S?
CURASIGHT A/S most recently used PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB.
When was CURASIGHT A/S founded?
CURASIGHT A/S was founded on 22 May 2013.
What is the equity of CURASIGHT A/S?
Equity was DKK 17.9m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.